Robin Bellas
Partner
Robin has been a Partner at Morgenthaler since 1984 after working for ten years in general management in emerging growth companies. He was General Manager of the Electronics division of Harshaw before joining Morgenthaler. Earlier, Robin held marketing roles at Acurex, a venture-backed startup in Mountain View, California. After business school, Robin began his career at SHM Nuclear, a startup in Sunnyvale, California that was acquired by EMI Medical.
Robin has been responsible for Morgenthaler’s investment in numerous health care and information technology companies that have completed public offerings or successful mergers. He is a Director of CareMedic Systems, ForSight Vision3, ForSight Vision4, IPC The Hospitalist Company (IPCM), Transcend Medical and Vertiflex. He was a founding Director of Medical Technology Group (MTG), Morgenthaler's first medical device incubator. Robin is a founding Director of The Foundry, Morgenthaler's current medical device incubator, and was a Director of many of its startups, including Ardian Medical, Cabochon Aesthetics, and Satiety. In addition, he is a founding Director of ForSight Labs, Morgenthaler’s newest medical device incubator, focused on medical device solutions in ophthalmology.
Robin is a past Director of the Western Association of Venture Capitalists and of the Stanford Business School Trust. Before Stanford, he served as a line officer on nuclear fast attack and ballistic missile submarines. Robin received a BS in Engineering from the United States Naval Academy, and is a two-time Heavyweight Crew National Champion. He also has an MBA from the Stanford Graduate School of Business. Robin and Terrye have two grown daughters and live in Portola Valley, California. He can be reached at rbellas@morgenthaler.com.
Education:
United States Naval Academy ( B.S. in Engineering ), Stanford University ( M.B.A.).
Board Seats:
- CareMedic
- ForSight Labs
- ForSight Vision3
- ForSight Vision4
- IPC - The Hospitalist Company
- Transcend
- Vertiflex
Focus:
Life sciences
Other Investments:
Arbor Health Care (acquired by Extendicare (EXE)), Athena Neurosciences (acquired by Elan Corp., plc (ELN)), CardioThoracic Systems (acquired by Guidant (GDT)), Embol-X (acquired by Edwards Lifesciences (EW)), Executone (acquired by Isoetec ), LuMend, Managed Health Network (acquired by Foundation Health (FHS)), Medaphis (acquired by Per-Sé (PSTI)), National Medical Diagnostics (acquired by General Electric (GE)), Perclose (acquired by Abbott Labs (ABT)), Sequana Therapeutics (acquired by Axys Pharmaceutical (AXPH)), Surgical Health (acquired by HealthSouth (HRC)), The Liposome Company, Thermage, VeriFone (acquired by HP (PAY)), and Vical
Portfolio News:
- Ardian: Succeeding Where Drugs Fail
- Health Overhaul Opens Opportunities
- IPC's Singer honored as Physician Entrepreneur of the Year
- IPC's IPO Enjoys Healthy Public Reception
- IPC-The Hospitalist Co. Mulls IPO Prospects
- Medical devices: Silicon Valley’s emerging glamour sector
- The heart device company hopes to raise funds to pump into drug-eluting stents
- Surviving as a Stent Startup
- Are Migraines All in Your Heart?
